ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

Panel to Hear Innovation Reports

August 26, 1988

Funding opportunities listed.

February 20, 2004